GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China
· Delayed Price · Currency is CNY 19.04
-0.15 (-0.78%)
Apr 30, 2025, 3:00 PM CST
SHA:600771 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 105.88 | 83.6 | 90.08 | -250.02 | -316.24 | 32 | Upgrade
|
| Depreciation & Amortization | 53.54 | 53.54 | 43.14 | 39.25 | 38.39 | 34.68 | Upgrade
|
| Other Amortization | 0.61 | 0.61 | 5.43 | 3.12 | 3.14 | 3.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -0.2 | 0.02 | -0.4 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 12.16 | 12.16 | 0.02 | 19.89 | 0.03 | -0.9 | Upgrade
|
| Loss (Gain) From Sale of Investments | 7.73 | 7.73 | -1.45 | 0.92 | 4.22 | 2.27 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 24.76 | 22.2 | -26.03 | 60.55 | Upgrade
|
| Other Operating Activities | 58.97 | 76.45 | 23.08 | 51.84 | 8.14 | 28.35 | Upgrade
|
| Change in Accounts Receivable | 289.01 | 289.01 | 221.08 | 352.25 | 228.78 | -273.12 | Upgrade
|
| Change in Inventory | -204.87 | -204.87 | -157.6 | -59.63 | 9.76 | 161.14 | Upgrade
|
| Change in Accounts Payable | -190.49 | -190.49 | -25.66 | 86.1 | 155.62 | -107.42 | Upgrade
|
| Operating Cash Flow | 117.19 | 112.39 | 215.5 | 253.43 | 81.37 | -75.52 | Upgrade
|
| Operating Cash Flow Growth | -43.84% | -47.85% | -14.96% | 211.45% | - | - | Upgrade
|
| Capital Expenditures | -9.6 | -8.78 | -2.51 | -8.67 | -18.19 | -49.65 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.23 | 0.03 | 0 | 1.06 | Upgrade
|
| Investment in Securities | -9.98 | 1.56 | 0.35 | 0.2 | -0.55 | -10.9 | Upgrade
|
| Other Investing Activities | - | - | 0.74 | 1.02 | 0.86 | 0.82 | Upgrade
|
| Investing Cash Flow | -19.54 | -7.17 | -1.19 | -7.41 | -17.89 | -58.67 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 51.62 | 206.5 | - | Upgrade
|
| Long-Term Debt Issued | - | - | 56 | 355 | 301.86 | 508 | Upgrade
|
| Total Debt Issued | - | - | 56 | 406.62 | 508.36 | 508 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -229.5 | -288.22 | - | Upgrade
|
| Long-Term Debt Repaid | - | -245.6 | -242.98 | -260.32 | -309.8 | -207.43 | Upgrade
|
| Total Debt Repaid | -245.6 | -245.6 | -242.98 | -489.82 | -598.02 | -207.43 | Upgrade
|
| Net Debt Issued (Repaid) | -245.6 | -245.6 | -186.98 | -83.19 | -89.67 | 300.57 | Upgrade
|
| Common Dividends Paid | -1.29 | -3.95 | -14.33 | -19.8 | -18.31 | -11.04 | Upgrade
|
| Other Financing Activities | -2.91 | 2.77 | - | - | - | -168.75 | Upgrade
|
| Financing Cash Flow | -249.8 | -246.78 | -201.31 | -102.99 | -107.98 | 120.78 | Upgrade
|
| Net Cash Flow | -152.14 | -141.56 | 13 | 143.03 | -44.5 | -13.42 | Upgrade
|
| Free Cash Flow | 107.59 | 103.61 | 212.99 | 244.76 | 63.17 | -125.17 | Upgrade
|
| Free Cash Flow Growth | -47.93% | -51.35% | -12.98% | 287.44% | - | - | Upgrade
|
| Free Cash Flow Margin | 8.31% | 8.48% | 16.59% | 21.65% | 7.40% | -11.28% | Upgrade
|
| Free Cash Flow Per Share | 0.22 | 0.21 | 0.43 | 0.50 | 0.13 | -0.27 | Upgrade
|
| Cash Income Tax Paid | 137.93 | 144.12 | 142.15 | 111.09 | 126.71 | 149.03 | Upgrade
|
| Levered Free Cash Flow | 110.91 | 134.48 | 163.44 | 553.83 | -124.2 | -1.03 | Upgrade
|
| Unlevered Free Cash Flow | 110.91 | 134.48 | 174.03 | 566.93 | -112.27 | 7.06 | Upgrade
|
| Change in Net Working Capital | 50.48 | 26.82 | -57.23 | -674.9 | -91.17 | -10.41 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.